$159.57
▲ +1.4% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
ICUI: Raising target price to $167.00
Analyst Report: ICU Medical, Inc.
ICUI: Lowering target price to $161.00
Overview
52-week range
$107
$160
99% of range
Avg surprise (last 3)
+41.2%
Avg reaction (last 2)
+4.6%
100% positive
Latest IV / EM
54%
EM ±12.3% · $155 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $1.55 | $1.33 | +16.5% | +15.7% | +2.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.14 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $1.66 | $1.14 | +45.6% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $1.34 | $0.83 | +61.5% | — | +6.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.35 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.88 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.63 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.30 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.41 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | $1.49 | $1.66 | -10.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $530M | — | $537M | $549M | $605M | — | $589M | $596M |
| Cost of revenue | $324M | — | $336M | $341M | $395M | — | $384M | $389M |
| Gross profit | $206M | — | $201M | $208M | $210M | — | $205M | $207M |
| Operating income | $14M | — | $14M | $11M | $13M | — | $8M | $8M |
| Net income | $30M | — | $-3M | $35M | $-15M | — | $-33M | $-21M |
| EPS (diluted) | $1.20 | — | $-0.14 | $1.43 | $-0.63 | — | $-1.35 | $-0.88 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $606M | $616M | $622M | $616M | $590M | $585M | $692M | $683M |
| Total current assets | $1.21B | $1.19B | $1.21B | $1.18B | $1.42B | $1.44B | $1.26B | $1.24B |
| Total assets | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B |
| Long-term debt | $1.26B | $1.27B | $1.31B | $1.34B | $1.49B | $1.53B | $1.54B | $1.55B |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $2.11B | $2.12B | $2.13B | $2.12B | $1.99B | $1.97B | $2.05B | $2.04B |